Arterial Occlusive Diseases Clinical Trials

6 recruitingLast updated: July 25, 2026

There are 6 actively recruiting arterial occlusive diseases clinical trials across 7 countries. Studies span Not Applicable. Top locations include Barcelona, Spain, Boston, Massachusetts, United States, Charleston, West Virginia, United States. Updated daily from ClinicalTrials.gov.


Arterial Occlusive Diseases Trials at a Glance

6 actively recruiting trials for arterial occlusive diseases are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Barcelona, Boston, and Charleston. Lead sponsors running arterial occlusive diseases studies include Fundación EPIC, Centre Hospitalier Universitaire de Saint Etienne, and Fondazione Ricerca e Innovazione Cardiovascolare ETS.

Browse arterial occlusive diseases trials by phase

Treatments under study

About Arterial Occlusive Diseases Clinical Trials

Looking for clinical trials for Arterial Occlusive Diseases? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Arterial Occlusive Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Arterial Occlusive Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Not Applicable

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

Arterial Occlusive DiseasesPainCardiovascular Diseases+12 more
Teleflex1,859 enrolled2 locationsNCT07258290
Recruiting
Not Applicable

A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)

Arterial Occlusive DiseasesCardiovascular DiseasesMyocardial Ischemia+4 more
Fundación EPIC700 enrolled13 locationsNCT07286578
Recruiting
Not Applicable

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Arterial Occlusive DiseasesCardiovascular DiseasesCoronary Disease+22 more
Fondazione Ricerca e Innovazione Cardiovascolare ETS576 enrolled1 locationNCT06535568
Recruiting
Not Applicable

Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke

Arterial Occlusive DiseasesThrombectomyStroke
Fundación EPIC200 enrolled4 locationsNCT05930145
Recruiting

Spectroscopy in Functional Assessment of Peripheral Artery Disease (spectroAMI)

Arterial Occlusive Diseases
Centre Hospitalier Universitaire de Saint Etienne40 enrolled1 locationNCT03723473
Recruiting

BASIL Study: A randomised comparison study on the treatment of calcified (hard and concrete-like) coronary artery using the conventional balloon angioplasty prior stenting versus the use of Shockwave Intravascular Lithotripsy (S-IVL) prior to stenting.

Arterial Occlusive DiseasesCalcified Coronary ArteriesCardiovascular Diseases+6 more
Shockwave Medical60 enrolled1 locationACTRN12620000086965